|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.420 USD | +0.43% |
|
-2.48% | -1.05% |
| Capitalization | 1.25B 1.07B 1.01B 937M 1.73B 112B 1.88B 11.76B 4.54B 53.05B 4.68B 4.58B 194B | P/E ratio 2025 * |
14.9x | P/E ratio 2026 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise value | 3.01B 2.59B 2.42B 2.26B 4.17B 271B 4.53B 28.32B 10.94B 128B 11.29B 11.05B 467B | EV / Sales 2025 * |
0.93x | EV / Sales 2026 * | 0.89x |
| Free-Float |
75.16% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: AdaptHealth Corp.
| 1 day | +0.43% | ||
| 1 week | -2.48% | ||
| Current month | -2.48% | ||
| 1 month | -1.98% | ||
| 3 months | -0.95% | ||
| 6 months | +5.84% | ||
| Current year | -1.05% |
| 1 week | 9.27 |  | 9.84 |
| 1 month | 8.99 | | 10.21 |
| Current year | 7.1 | | 11.63 |
| 1 year | 7.1 | | 11.63 |
| 3 years | 6.37 | | 23 |
| 5 years | 6.37 | | 41.58 |
| 10 years | 6.37 | | 41.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Suzanne Foster
CEO | Chief Executive Officer | 55 | 2024-05-19 |
Jason Clemens
DFI | Director of Finance/CFO | 47 | 2020-08-02 |
Toby Barnhart
COO | Chief Operating Officer | 57 | 2024-09-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Terence Connors
BRD | Director/Board Member | 70 | 2017-06-30 |
Susan Weaver
BRD | Director/Board Member | 64 | 2018-01-31 |
Dale Wolf
CHM | Chairman | 71 | 2024-06-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | -2.48% | -3.19% | -56.49% | 1.25B | |
| -0.26% | -2.96% | +8.20% | +20.43% | 217B | |
| -0.62% | -3.77% | +20.65% | +31.50% | 130B | |
| +0.60% | -7.93% | +39.54% | +100.60% | 65.89B | |
| +0.10% | -0.03% | -11.84% | -20.64% | 55.36B | |
| +0.25% | +1.92% | +17.82% | +76.38% | 52.03B | |
| +0.87% | -1.13% | +21.95% | +43.42% | 25.84B | |
| +0.37% | +3.18% | -15.74% | -43.94% | 25.54B | |
| -0.33% | +2.89% | +18.63% | -34.55% | 24.14B | |
| -2.23% | -2.91% | -23.08% | +19.35% | 22.48B | |
| Average | -0.08% | -1.32% | +7.29% | +13.61% | 62B | |
| Weighted average by Cap. | -0.17% | -2.43% | +11.99% | +28.27% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.23B 2.78B 2.6B 2.43B 4.48B 291B 4.87B 30.43B 11.75B 137B 12.13B 11.87B 502B | 3.45B 2.97B 2.78B 2.59B 4.78B 311B 5.2B 32.5B 12.55B 147B 12.95B 12.68B 536B |
| Net income | 88.48M 76.05M 71.25M 66.41M 123M 7.96B 133M 833M 322M 3.76B 332M 325M 13.75B | 130M 112M 105M 97.82M 181M 11.73B 197M 1.23B 474M 5.54B 489M 479M 20.26B |
| Net Debt | 1.76B 1.51B 1.42B 1.32B 2.44B 158B 2.65B 16.57B 6.4B 74.78B 6.6B 6.46B 273B | 1.82B 1.56B 1.46B 1.36B 2.52B 164B 2.74B 17.13B 6.61B 77.3B 6.83B 6.68B 283B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 9.420 $ | +0.43% | 506,703 |
| 25-12-04 | 9.380 $ | +0.43% | 968,484 |
| 25-12-03 | 9.340 $ | -0.95% | 979,720 |
| 25-12-02 | 9.430 $ | -3.28% | 1,101,039 |
| 25-12-01 | 9.750 $ | +0.93% | 1,192,109 |
Delayed Quote Nasdaq, December 05, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AHCO Stock
Select your edition
All financial news and data tailored to specific country editions
